Az To File Triple Combination Therapy For Copd | Latest News RSS feed

Az To File Triple Combination Therapy For Copd - Latest News

AZ to file triple combination therapy for COPD

Global Medicines at AZ, said: “We are encouraged by the results of the KRONOS trial which demonstrate PT010’s efficacy in improving lung function and its potential value as a triple combination ... read more

AZ prepares to file COPD triple, taking on rival GSK

AstraZeneca has said it is ready to file for approval of its chronic obstructive pulmonary disease (COPD) triple therapy before the end ... reducing attacks by 52% compared to AZ’s LAMA/LABA ... read more

AZ to file COPD combo in China and Japan

AstraZeneca is planning filings of its chronic obstructive pulmonary disease drug Bevespi Aerosphere in China and Japan ... and Chiesi has got its COPD triple therapy Trimbow approved in Europe and is ... read more

Looking for another news?

Glaxo accelerates regulatory plan for triple combo therapy for COPD; NDA filing expected by year end

Buoyed by discussions with the FDA, GlaxoSmithKline (NYSE:GSK) plans to file its New Drug Application (NDA) seeking approval of its triple combination therapy for the treatment of chronic obstructive ... read more

GSK plans to file an NDA with US FDA for once-daily closed triple combo therapy FF/UMEC/VI in patients with COPD

GlaxoSmithKline plc (GSK) and Innoviva, Inc announced that, following discussions with the US Food and Drug Administration (FDA), GSK has brought forward the plan to file a New ... of the closed ... read more

Vertex cystic fibrosis triple combo therapy succeeds in important trials

(Reuters) - Vertex Pharmaceuticals Inc on Wednesday said its triple-combination treatment for cystic fibrosis led to significant lung function improvement in ... 2 percent as the company said it would ... read more

AZ’ triple combo COPD inhaler hits PhIII targets

AstraZeneca recently unveiled top-line trial data backing use of an experimental triple combination therapy being ... characterise the role of this potential treatment for patients with COPD,” said AZ ... read more

Vertex cystic fibrosis triple combo therapy succeeds in important trials

Vertex, which had earlier expected to file ... lung function. The backbone drugs in the triple combinations are ivacaftor and tezacaftor, which make up Symdeko. Ivacaftor is also sold as a standalone ... read more

GSK files first application for triple COPD therapy

GlaxoSmithKline has submitted its three-in-one treatment for chronic obstructive pulmonary disease (COPD) in the US, more than a year earlier than planned. GSK had previously suggested it would file ... read more

Vertex to file for approval of cystic fibrosis therapy in 2019

May 30 (Reuters) - Vertex Pharmaceuticals Inc said on Thursday it will apply for regulatory approval later this year for its triple ... in serious lung infections, declining lung function and often ... read more

AZ boosted by COPD triple inhaler results

AZ’s single inhaler, PT010, showed statistically significant improvement in eight of nine lung ... and could file in the US and Europe next year. GlaxoSmithKline’s Trelegy is approved in the EU and US ... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us